Amphista Therapeutics Limited Is A Biotechnology Company Dedicated To Developing Innovative Treatments For Severe Diseasesincluding Cancerfounded By Advent Life Sciencesit Originated From The Laboratory Of Professor Alessio Ciulli At The University Of Dundeethe Company Was Incorporated On December 202017And Is Based In Cambridgeengland Amphista Is Advancing A Novel Approach To Targeted Protein Degradationtpdby Utilizing A Broader Range Of The Body S Protein Degradation Mechanismsits Primary Product Consists Of Next Generation Bifunctional Molecules That Modulate The Abundance Of Disease Related Proteins By Engaging The Cell S Degradation Machinerythis Technology Allows Amphista To Target A Wider Spectrum Of Diseasesthe Company Has Established Collaborations With Major Pharmaceutical Firmsincluding A Significant Milestone With Bristol Myers Squibband Has Secured Over $60 Million In Funding From Prominent Life Science Investors
